申请人:Kolczewski Sabine
公开号:US20090227628A1
公开(公告)日:2009-09-10
The present invention is concerned with 2-aminoquinoline derivatives of formula I
wherein Z, R1, and Ar1 are as defined herein, pharmaceutical compositions containing them, methods for their manufacture. The compounds are 5-HT
5A
receptor antagonists and are useful in the prevention and/or treatment of depression, anxiety disorders, schizophrenia, panic disorders, agoraphobia, social phobia, obsessive compulsive disorders, post-traumatic stress disorders, pain, memory disorders, dementia, disorders of eating behaviors, sexual dysfunction, sleep disorders, abuse of drugs, motor disorders such as Parkinson's disease, psychiatric disorders or gastrointestinal disorders.
本发明涉及公式I的2-氨基喹啉衍生物,其中Z、R1和Ar1的定义如本文所述,以及含有它们的药物组合物、其制造方法。这些化合物是5-HT5A受体拮抗剂,可用于预防和/或治疗抑郁症、焦虑障碍、精神分裂症、惊恐障碍、广场恐惧症、社交恐惧症、强迫症、创伤后应激障碍、疼痛、记忆障碍、痴呆、进食行为障碍、性功能障碍、睡眠障碍、药物滥用、帕金森病等运动障碍、精神障碍或胃肠道障碍的治疗。